References in periodicals archive ?
Molecular epidemiology of Crimean-Congo Hemorrhagic Fever virus genome isolated from ticks of Hamadan province of Iran.
Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response.
Experimental vector incompetence of a soft tick, Ornithodoros sonrai (Acari: Argasidae), for Crimean-Congo hemorrhagic fever virus.
Migratory birds, ticks, and Crimean-Congo hemorrhagic fever virus.
Factors associated with IgG positivity to Crimean-Congo hemorrhagic fever virus in the area with the highest seroprevalence in Greece.
Recombinant nucleoprotein-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus.
Bavituximab is a monoclonal antibody that in preclinical studies has demonstrated encouraging activity against diverse viruses, including a hemorrhagic fever virus.
Distribution of Crimean-Congo hemorrhagic fever virus (CCHFV)-positive persons, by age group, Turkey, January-April 2009.
Risk of human infections with CrimeanCongo hemorrhagic fever virus in a South African rural community.
To the Editor: Crimean-Congo hemorrhagic fever virus (CCHFV; family Bunyaviridae, genus Nairovirus) causes outbreaks of severe hemorrhagic fever in humans, with case-fatality rates [less than or equal to] 30% (1,2).
To the Editor: Crimean Congo hemorrhagic fever, a tick-borne illness caused by Crimean Congo hemorrhagic fever virus (CCHFV), is endemic to Africa, the Balkans, the Middle East, and parts of Asia.
Sporadic infections caused by Crimean-Congo hemorrhagic fever virus (CCHFV) occur as well.
Full browser ?